Block Drug OTC Small Packaging Denial Mishandled By FDA, CHPA Says
This article was originally published in The Rose Sheet
Executive Summary
FDA mishandled its decision to deny Block Drug a small packaging exemption by assuming off-label information could not be easily read and interpreted by consumers, the Consumer Healthcare Product Association maintains in Oct. 3 comments to the agency.
You may also be interested in...
OTC Labeling Reg Deferral For Convenience Size OTCs To Be Issued By FDA
FDA will publish a notice to "delay the compliance date of the current Drug Facts rules with respect to 'convenience-size' drug packages" in an upcoming issue of the Federal Register, the agency says in a recent letter to Lil' Drug Store Products
OTC Labeling Reg Deferral For Convenience Size OTCs To Be Issued By FDA
FDA will publish a notice to "delay the compliance date of the current Drug Facts rules with respect to 'convenience-size' drug packages" in an upcoming issue of the Federal Register, the agency says in a recent letter to Lil' Drug Store Products
Block Exemption Request Differentiates "Label" From "Labeling"
Block Drug's request for an exemption from the OTC labeling final rule complies with provisions of the FD&C Act that differentiate a product's "label" from "labeling," the company says in a Dec. 22 letter to FDA.